Objectives: The Food and Drug Administration recommends that retrievable inferior vena cava filters (IVCF) be removed between 25 and 54 days post insertion. Nationally, the retrieval rate is abysmally low. The objectives of this study are to (1) assess if a retrieval plan and access to an office endovascular center (OEC) will increase retrieval rates, and (2) assess the safety of the procedure in an OEC.
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Methods: In this institution review board-approved retrospective study, the medical records of patients who had an IVCF placed and/or removed in the hospital and OEC setting between January 2011 and January 2017 were analyzed. Demographic data collected include: hypercoagulable status, indication for insertion, point of entry, filter model, procedure site, documented retrieval plan, number of removal attempts, point of entry for removal, complications attributed to removal, success of removal, and the duration that the filter was in place. Anticoagulation was continued before filter retrieval. Filters were removed under local anesthesia or mild conscious sedation.
Results: IVCF retrieval was attempted in 116 of 214 patients, while the rest were lost to follow-up, died, or the indication changed. Of the patients who had filters placed in the hospital, 76% (n ¼ 83) had a removal attempt in the OEC, while 14% had the filter removed in the hospital. Patients who had IVCFs inserted in an OEC had their filters removed in the OEC only. A documented retrieval plan was found in the medical record of 95% of patients. All filters were removed via the jugular approach, resulting in 99 of 101 successful removals (98%) in the OEC. There was no mortality related to filter removal. Additionally, there were no bleeding complications, despite the fact that patients remained on anticoagulant therapy during the removal. In 4% of patients, the filter was removed in less than 3 weeks, 29% of patients between 3 and 6 weeks, 26% of patients between 6 weeks and 3 months, and 40% of patients after 3 months. The most common filter removed was the Celect Cook (42.3%), followed by Eclipse Bard (18.8%), and Denali Bard (17.9%). Various other filters made up the remaining 21% (Fig) .
Conclusions: The incidence of removal of retrievable filters improves with a well-documented removal plan. Access to an OEC further helps increase the frequency of removal because of ease of access. Furthermore, retrievable filters can be safely removed in an OEC with extremely high success rates (98%). Finally, anticoagulation therapy can be continued during retrieval attempt without untoward complications.
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